The Illumina Propel Certification Program provides your lab with the opportunity to demonstrate competency with select Illumina products through a carefully designed, standardized process. Becoming Propel-Certified also means your lab can gain access to a powerful set of benefits designed to accelerate, differentiate, and propel your lab forward.Learn More
With mentorship, financial support, and access to sequencers and reagents, we're helping genomics startups launch so we can unlock the power of the genome—together.Illumina Accelerator Startup Funding
Some of our existing partnerships include:
Illumina and Loxo Oncology to partner on developing next-generation sequencing-based pan-cancer companion diagnostics.Read Article
Bristol-Myers Squibb and Illumina announce strategic collaboration to develop and commercialize companion diagnostics for Bristol-Myers Squibb’s oncology immunotherapies.Read Article
Illumina announces strategic collaboration with Merck Serono to expand companion diagnostics for oncology.Read Article
Discover how Illumina is partnering with others.
llumina and the Broad Institute are partnering to co-develop a suite of secondary genomic analysis pipelines. The partnership will result in new methods, integrating Illumina’s DRAGEN™ Pipelines and technology with Broad’s Genome Analysis Toolkit (GATK).Read More